News

Rare Blood Clots Detected In Individuals Who Received The AstraZeneca Vaccine

Rare Blood Clots Detected In Individuals Who Received The AstraZeneca Vaccine

Recipients of the AstraZeneca vaccine have developed a rare blood syndrome, a recent study finds. What does it mean? Covishield, the vaccine which has been jointly formulated by the Oxford University and the British pharmaceutical giant AstraZeneca, have supposedly become the cause for a rare blood clot among recipients in the UK. However, scientists are saying that the numbers are too low and the perks of the vaccine far exceed the downsides it might offer.

Rare Blood Clots Detected In Individuals Who Received The AstraZeneca Vaccine

The Medicines and Healthcare products Regulatory Agency, which is formally abbreviated to MHRA, administers a yellow card scheme which is responsible for finding suspected side effects and other concerns for drugs and medical devices.

Rare Blood Clots Detected In Individuals Who Received The AstraZeneca Vaccine

According to the latest data from the MHRA, an estimate of 30 recipients have reportedly developed a  blood clot in the brain, which is known as cerebral venous sinus thrombosis or CVST.  This uncommon syndrome occurs when a blood clot develops in the brain’s venous sinuses. It has an array of symptoms that are associated with it including fainting, seizures, headaches and blurry vision. 

Not only that, but the study has also revealed that the recipients who had contracted the syndrome simultaneously exhibited a low platelet count. Furthermore, eight other recipients have reported other blood clotting problems accompanied with low platelets.

So far, the numbers of the reported cases remain low. Nearly 30 individuals, out of the 18.1 million doses of the AstraZeneca vaccine that had been administered, have reported of the clots-the rate of around one case per 600,000 shots.

Two recipients who had received the Pfizer-BioNTech vaccine, have also reported of developing the blood clot. However, neither of the two cases showed a low platelet count.

Concerns over these occurrences among recipients have grappled the citizens. The MHRA along with the European Medicines Agency(EMA) have firmly emphasized that there is no evidence for believing that these events have been caused by the vaccine. Moreover,the perks of the vaccine far outnumber the downsides that might result from the jabs, considering the dangers posed by the vicious Corona virus. Regardless, the EMA has announced that a warning about these events will be put up on the vaccine information while they continue to investigate into the matter.

According to the EMA, it had gotten 14 reports of deaths associated with uncommon blood clots in individuals who had received jabs of the vaccine. This has resulted in a nation-wide terror. Many countries have recommenced the use of vaccines after briefly pausing but many remain apprehensive. For instance, Canada has put a curb on vaccine administration for individuals under the age of 55. Similarly, Germany has put a curb on vaccine administration for individuals under the age of 60. The latter has detected 31 reports of CVST after providing 2.7 million doses of the AstraZeneca vaccine. 19 individuals out of those 31 have reported low platelet counts while 9 have died.

Presently, it has been observed that this rare clot is primarily developing in women under the age of 65; however, it remains unknown why.

At first, Germany was reluctant to approve the vaccine for older people, resulting in majority of the recipients being young, comprising mainly of teachers and healthcare workers, most of whom are women. This might explain the contrast with UK, which had permitted the vaccine for older people. 

Expert Hematology Panel or EHP of the British Society have stated that blood clots accompanied by low platelets after vaccine jabs have been reported as affecting individuals of all ages and both genders. The MHRA continues to investigate the matter. 

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top